World of DTC Marketing
JANUARY 20, 2022
Many pharma brands are making mistakes when calculating and ranking channel value. Understanding these trends allows brands to build lasting relationships with customers, improve lead generation, and increase customer lifetime value. Pharma has historically focused a significant portion of its marketing budgets on paid search.
Pharma Marketing Network
OCTOBER 6, 2021
Targeting and attribution challenges are universal, but pharmaceutical advertisers encounter several unique hurdles with digital advertising. Given their often niche content, pharma marketers must target smaller, more exclusive audiences to drive results while developing impactful creative.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
DECEMBER 17, 2021
The pharma industry has been slower to embrace digital technologies than other less-regulated sectors but the COVID-19 pandemic has greatly changed this long-standing mindset. In 2020 and 2021, we saw pharma forced to become more flexible and open-minded than ever before. A Continued Boost in Pharma’s Reputation.
PM360
JANUARY 25, 2023
Spurred into action by the pandemic, many pharma brands are undertaking or accelerating their digital transformations. As a relative newcomer to pharma (I joined the industry in 2019), several things stand out about the industry’s approach to digital. There are a few key differences in pharma that made this happen.
pharmaphorum
NOVEMBER 17, 2022
She is proficient in written, verbal, and digital media for both internal pharma, including MSL training modules, and external communications, and has worked with US and International thought leads in breast and lung cancer developing publications, symposia, and large summit meetings.
Pharma Marketing Network
SEPTEMBER 15, 2021
For more information please contact: Ria Kiayia, Digital Media and PR Marketing Executive at riak@marcusevanscy.com or visit: [link]. The post EU Medical Device Safety Monitoring & Reporting Conference | October 26-28, 2021 | Berlin, Germany and Virtual appeared first on Pharma Marketing Network. REGISTER TODAY.
PM360
MARCH 24, 2023
We covered the first one by looking at Organizational Structures , today, let’s dive into the second which is the toughest, not just for pharma, but for the entire country: Diversity, Equity, and Inclusion (DE&I). When we look at DE&I in pharma, how well we are doing depends on who you ask. population. Another fun fact—the U.S.
Expert insights. Personalized for you.
232 
Let's personalize your content